prof. dr. A.C.G. (Toine) Egberts

prof. dr. A.C.G. (Toine) Egberts

Full Professor

Show full profile

Research Output (556)

The Nature, Causes, and Clinical Impact of Errors in the Clinical Laboratory Testing Process Leading to Diagnostic Error:A Voluntary Incident Report Analysis

van Moll Christel, Egberts Toine, Wagner Cordula, Zwaan Laura, Ten Berg Maarten 4 Oct 2023, In: Journal of Patient Safety. 19 , p. 573-579 7 p.

Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019

Alsamil Ali M, Gardarsdottir Helga, Leufkens Hubert G, Egberts Toine C, Giezen Thijs J Oct 2023, In: Drug Discovery Today. 28 7 p.

Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer:real-world outcomes versus clinical trial results

Verschueren Marjon V, Dijs Talitha, Gulikers Judith L, Veelen Ard van, Croes Sander, Hendriks Lizza El, Smit Adrianus Aj, Bloem Lourens T, Egberts Antoine CG, van de Garde Ewoudt Mw, Peters Bas Jm 1 Aug 2023, In: Immunotherapy. 15 , p. 839-851 13 p.

Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation:a single day versus a multiday therapeutic drug monitoring regimen

Bognàr T Tim, Kingma J S Jurjen, Smeijsters E H Erin, van der Elst K C M Kim, de Kanter C T M Klaartje, Lindemans C A Caroline, Egberts A C G Toine, Bartelink I H Imke, Lalmohamed A Arief Jul 2023, In: Bone Marrow Transplantation. 58 , p. 762-768 7 p.

DosEmi study protocol:a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A

Donners Anouk, van der Zwet Konrad, Egberts Antoine C G, Fijnvandraat Karin, Mathôt Ron, Kruis Ilmar, Cnossen Marjon H, Schutgens Roger, Urbanus Rolf T, Fischer Kathelijn 26 Jun 2023, In: BMJ Open. 13

Frequentie en acceptatie van door beslisondersteuning gegenereerde STOPP/START-signalen bij ouderen met polyfarmacie en multimorbiditeit opgenomen in het ziekenhuis

Sallevelt Bastiaan, Huibers Lianne, Heij Jody Op, Egberts Toine, van Puijenbroek Eugène, Wilting Ingeborg, Knol Wilma 2 Jun 2023, In: Pharmaceutisch Weekblad. 158 , p. 21-28 8 p.

Recommendations on TNFα inhibitor biosimilar use in clinical practice:a comparison of European gastroenterology IBD guidance

Meijboom Rosanne W, Barbier Liese, Druedahl Louise C, Sarnola Kati, Tolonen Hanna M, Gardarsdottir Helga, Egberts Toine C G, Giezen Thijs J 23 Mar 2023, In: Expert Opinion on Biological Therapy. 23 , p. 801-817 17 p.

Combining text mining with clinical decision support in clinical practice:a scoping review

van de Burgt Britt W M, Wasylewicz Arthur T M, Dullemond Bjorn, Grouls Rene J E, Egberts Toine C G, Bouwman Arthur, Korsten Erik M M 1 Mar 2023, In: Journal of the American Medical Informatics Association. 30 , p. 588-603 16 p.

Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy

de Jong Corine, Herder Gerarda J M, van Haarlem Simone W A, van der Meer Femke S, van Lindert Anne S R, Ten Heuvel Alexandra, Brouwer Jan, Egberts Toine C G, Deneer Vera H M 7 Jan 2023, In: Genes. 14

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar

Meijboom Rosanne W, Gardarsdottir Helga, Becker Matthijs L, Movig Kris L L, Kuijvenhoven Johan, Egberts Toine C G, Giezen Thijs J 1 Jan 2023, In: Therapeutic Advances in Gastroenterology. 16 15 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not